Table 1. Patient and tumour characteristics (n=102).

	Patients treated with anthracyclines (n=44)		Patients treated with taxane–trastuzumab (n=58)
	N	%	N	%	P
Age (years)
<50	24	54	32	55
⩾50	20	46	26	45	0.89
Tumour initial stage
T2	18	41	36	62
T3–T4	26	59	22	38	0.06
Axillary nodal status
Positive	38	86	35	60
Negative	6	14	23	40	0.01
Tumour grade
I+II	18	41	37	64
III	26	59	21	36	0.04
Oestrogen receptor
Positive	17	39	33	57
Negative	27	61	25	43	0.10
Pathological complete response
Yes	8	18	24	41
No	36	82	34	59	0.02
T-bet+ infiltrates before CT
Yes	9	21	13	22
No	35	79	45	78	0.99
T-bet+ infiltrates after CT
Yes	7	16	29	50
No	37	84	29	50	0.0008
T-bet+ induction
Yes	6	14	22	38
No	38	86	36	62	0.01
Relapse
Yes	26	59	14	24
No	18	41	44	76	0.0007
Death
Yes	23	52	2	4
No	21	48	56	96	<0.0001

Abbreviation: CT=chemotherapy.